UNH
UnitedHealth Group Inc
$
244.670
- Overview
- Forecast
- Valuation
- Earnings
Line
|
Candle
1D
5D
1M
3M
6M
YTD
1Y
5Y
High
248.7457
Open
246.420
VWAP
243.31
Vol
11.37M
Mkt Cap
221.95B
Low
239.500
Amount
2.77B
EV/EBITDA(TTM)
7.82
Total Shares
920.39M
EV
274.44B
EV/OCF(TTM)
9.48
P/S(TTM)
0.54
UnitedHealth Group Incorporated is a healthcare company. The Company operates two businesses, Optum and UnitedHealthcare. Optum serves the healthcare marketplace, including patients and consumers, payers, care providers, employers, governments and life sciences companies, through its Optum Health, Optum Insight and Optum Rx businesses. UnitedHealthcare offers a full range of health benefits, simplifying the healthcare experience and providing affordable solutions. The Company’s segments include Optum Health, Optum Insight, Optum Rx and UnitedHealthcare. The UnitedHealthcare segment includes UnitedHealthcare Employer & Individual, which serves consumers and employers; UnitedHealthcare Medicare & Retirement delivers health and well-being benefits to seniors and other Medicare-eligible consumers; and UnitedHealthcare Community & State serves consumers who are economically disadvantaged, the medically underserved and those without the benefit of employer sponsored health benefits coverage.
Show More
Market Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2026Q1
FY2025Q4
FY2025Q3
116.00B
+5.86%
6.808
-5.45%
114.05B
+13.14%
1.980
-70.93%
113.05B
+12.13%
2.921
-59.15%
Estimates Revision
The market is revising Downward the revenue expectations for UnitedHealth Group Incorporated (UNH) for FY2025, with the revenue forecasts being adjusted by -0.57% over the past three months. During the same period, the stock price has changed by -37.43%.
Revenue Estimates for FY2025
Revise Downward
-0.57%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
-38.19%
In Past 3 Month
Stock Price
Go Down
-37.43%
In Past 3 Month
26 Analyst Rating
49.16% Upside
Wall Street analysts forecast UNH stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for UNH is 364.96 USD with a low forecast of 270.00 USD and a high forecast of 520.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
19 Buy
6 Hold
1 Sell
Moderate Buy
49.16% Upside
Current: 244.670
Low
270.00
Averages
364.96
High
520.00
49.16% Upside
Current: 244.670
Low
270.00
Averages
364.96
High
520.00
Wells Fargo
Stephen Baxter
Overweight
downgrade
$306 -> $267
2025-08-04
New
Reason
Wells Fargo
Stephen Baxter
Price Target
$306 -> $267
2025-08-04
New
downgrade
Overweight
Reason
Wells Fargo analyst Stephen Baxter lowered the firm's price target on UnitedHealth to $267 from $306 and keeps an Overweight rating on the shares after hosting a meeting with management. The company appears to be confident in the achievability of reset guidance, the firm says. Wells thinks UnitedHealth is taking the right approach by in many cases adopting conservative assumptions on cost trend/margin recovery.
Bernstein
Outperform
to
Outperform
downgrade
$377 -> $337
2025-08-03
New
Reason
Bernstein
Price Target
$377 -> $337
2025-08-03
New
downgrade
Outperform
to
Outperform
Reason
Bernstein lowered the firm's price target on UnitedHealth to $337 from $377 and keeps an Outperform rating on the shares. The firm reduced estimates post the Q2 report to reflect the company's' lower earnings power base in 2025. However, it remains positive on UnitedHealth's earnings growth, driven by a turnaround for both the company and sector.
KeyBanc
Overweight
downgrade
$400 -> $350
2025-07-30
Reason
KeyBanc
Price Target
$400 -> $350
2025-07-30
downgrade
Overweight
Reason
KeyBanc lowered the firm's price target on UnitedHealth to $350 from $400 and keeps an Overweight rating on the shares. In the firm's view, the primary goal for UnitedHealth's Q2 report was to establish a credible EPS baseline to build on, which it thinks was accomplished. While the starting point is lower, KeyBanc believes UnitedHealth's outlook embeds areas of conservatism, most notably a higher MA cost assumption for the second half of 2025 compared to Q2. Additionally, the firm thinks comments on the 2027 EPS trajectory read positive for Stars in early October, which is the next catalyst.
BofA
Kevin Fischbeck
Neutral
downgrade
$300 -> $290
2025-07-30
Reason
BofA
Kevin Fischbeck
Price Target
$300 -> $290
2025-07-30
downgrade
Neutral
Reason
BofA analyst Kevin Fischbeck lowered the firm's price target on UnitedHealth to $290 from $300 and keeps a Neutral rating on the shares. The firm, which cut its estimates for the reset guidance and commentary that 2026 will see "solid, yet modest" EPS growth, argues that the $16 2025 EPS guidance "was less of a surprise, than the fact that 2026 won't be much higher." BofA rolls forward its valuation methodology to a more normalized year and tells investors that it sees the reset numbers as "more achievable."
Oppenheimer
Michael Wiederhorn
Outperform
downgrade
$400 -> $325
2025-07-30
Reason
Oppenheimer
Michael Wiederhorn
Price Target
$400 -> $325
2025-07-30
downgrade
Outperform
Reason
Oppenheimer analyst Michael Wiederhorn lowered the firm's price target on UnitedHealth to $325 from $400 and keeps an Outperform rating on the shares. The firm notes the company took an axe to numbers, re-instating 2025 adjusted-EPS guidance of $16.00-plus, which could prove to be trough earnings, as it returns to growth in 2026 and beyond. The 2025 guidance assumes the bottom-end or below target ranges across Medicare, Medicaid, Commercial, and OptumHealth, but should improve dramatically over the next two years as it re-prices the respective books. UnitedHealth expects "moderate" EPS growth in 2026, which will accelerate thereafter.
Piper Sandler
Overweight
downgrade
$353 -> $317
2025-07-30
Reason
Piper Sandler
Price Target
$353 -> $317
2025-07-30
downgrade
Overweight
Reason
Piper Sandler lowered the firm's price target on UnitedHealth to $317 from $353 and keeps an Overweight rating on the shares. The firm notes UnitedHealth's Q2 call was characterized by unprecedented transparency into business mix, earnings drivers and pricing assumptions/ cost trends across UnitedHealth and Optum. Piper recognizes that the company's $16.00 2025 adjusted EPS floor fell below the market's $18.00-$19.00 expectation, but it would be a buyer of the stock on weakness.
See All Ratings
Valuation Metrics
The current forward P/E ratio for UnitedHealth Group Inc (UNH.N) is 15.12, compared to its 5-year average forward P/E of 19.80. For a more detailed relative valuation and DCF analysis to assess UnitedHealth Group Inc 's fair value, click here.
Forward PE
The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
Strongly Undervalued
5Y Average PE
19.80
Current PE
15.12
Overvalued PE
22.06
Undervalued PE
17.54
Forward EV/EBITDA
The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
Strongly Undervalued
5Y Average EV/EBITDA
14.06
Current EV/EBITDA
10.75
Overvalued EV/EBITDA
15.57
Undervalued EV/EBITDA
12.55
Forward PS
The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
Strongly Undervalued
5Y Average PS
1.22
Current PS
0.49
Overvalued PS
1.42
Undervalued PS
1.03
Financials
Annual
Quarterly
FY2025Q2
YoY :
+12.91%
111.62B
Total Revenue
FY2025Q2
YoY :
-40.47%
5.15B
Operating Profit
FY2025Q2
YoY :
-19.20%
3.57B
Net Income after Tax
FY2025Q2
YoY :
-17.62%
3.74
EPS - Diluted
FY2025Q2
YoY :
+6.94%
6.30B
Free Cash Flow
FY2025Q2
YoY :
+272.05%
5.99
FCF Margin - %
FY2025Q2
YoY :
-28.41%
3.20
Net Margin - %
FY2025Q2
YoY :
+40.12%
13.90
ROIC
Trading Trends
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
179.7K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
439.0K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
5
31.6M
USD
Months
6-9
1
511.6K
USD
Months
0-12
0
0.0
USD
Months
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
0-3
Months
0.0
Volume
0
3-6
Months
547.1K
Volume
24
6-9
Months
3.4M
Volume
40
0-12
Months
0.0
Volume
0
Bought
0-3
1
165.3K
Volume
Months
3-6
31
2.4M
Volume
Months
6-9
45
3.4M
Volume
Months
0-12
0
0.0
Volume
Months
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
16.0K
USD
2
3-6
Months
251.0K
USD
13
6-9
Months
261.5K
USD
9
0-12
Months
115.5K
USD
3
Bought
0-3
2
40.5K
USD
Months
3-6
15
358.5K
USD
Months
6-9
3
97.5K
USD
Months
0-12
1
8.0K
USD
Months
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
0-3
Months
179.7K
USD
1
3-6
Months
0.0
USD
0
6-9
Months
0.0
USD
0
0-12
Months
439.0K
USD
1
Bought
0-3
0
0.0
USD
Months
3-6
5
31.6M
USD
Months
6-9
1
511.6K
USD
Months
0-12
0
0.0
USD
Months
UNH News & Events
Events Timeline
2025-08-07 (ET)
2025-08-07
15:21:19
Mixed options sentiment in UnitedHealth with shares down 1.0%
2025-08-07
11:36:30
DOJ requires divestitures to resolve challenge to UnitedHealth-Amedisys deal
2025-08-05 (ET)
2025-08-05
12:56:16
Moderately bullish activity in UnitedHealth with shares up 2.89%
Sign Up For More Events
Sign Up For More Events
News
9.5
08-06NASDAQ.COMPinnedIf You'd Invested $1,000 in UnitedHealth Group 3 Years Ago, Here's How Much You'd Have Today
9.5
08-05NASDAQ.COMPinnedUnitedHealth Group Just Released More Bad News. Should You Avoid the Stock?
6.5
08-07TipRanksStock Analyst Slams UnitedHealth (UNH) as ‘Gravely Overpriced’
Sign Up For More News
People Also Watch
ACN
Accenture PLC
241.720
USD
-2.35%
PFE
Pfizer Inc
24.230
USD
+1.25%
ABBV
AbbVie Inc
198.860
USD
+1.30%
CRM
Salesforce Inc
240.880
USD
-3.33%
PEP
PepsiCo Inc
143.920
USD
+2.22%
MCD
McDonald's Corp
307.910
USD
+0.08%
KO
Coca-Cola Co
70.430
USD
+1.32%
TMO
Thermo Fisher Scientific Inc
454.740
USD
+1.29%
ADBE
Adobe Inc
338.270
USD
-2.13%
BAC
Bank of America Corp
44.920
USD
-1.10%
FAQ
What is UnitedHealth Group Inc (UNH) stock price today?
The current price of UNH is 244.67 USD — it has decreased -0.45 % in the last trading day.
What is UnitedHealth Group Inc (UNH)'s business?
What is the price predicton of UNH Stock?
What is UnitedHealth Group Inc (UNH)'s revenue for the last quarter?
What is UnitedHealth Group Inc (UNH)'s earnings per share (EPS) for the last quarter?
What changes have occurred in the market's expectations for UnitedHealth Group Inc (UNH)'s fundamentals?
How many employees does UnitedHealth Group Inc (UNH). have?